A systematic review of middle meningeal artery embolization for minimally symptomatic chronic subdural haematomas that do not require immediate evacuation

Alvaro Rojas-Villabona, Saffwan Mohamed, Oliver Kennion, Rajeev Padmanabhan, Aslam Siddiqui, Manjunath Prasad, Nitin Mukerji, Alvaro Rojas-Villabona, Saffwan Mohamed, Oliver Kennion, Rajeev Padmanabhan, Aslam Siddiqui, Manjunath Prasad, Nitin Mukerji

Abstract

Introduction: Embolization of the Middle Meningeal Artery (EMMA) is an emerging treatment option for patients with Chronic Subdural Haematoma (CSDH).

Questions: (1) Can EMMA change the natural history of untreated minimally symptomatic CSDH which do not require immediate evacuation? (2) What is the role of EMMA in the prevention of recurrence following surgical treatment? (3) Can the procedure be performed under local anaesthetic?

Material and methods: Systematic literature review. No randomised clinical trials available on EMMA for meta-analysis.

Results: Six unique large cohorts with more than 50 embolisations were identified (evidence: 3b-4). EMMA can control the progression of surgically naïve CSDH in 91.1-100% of the patients, in which haematoma expansion is halted, or the lesion decreases and resolves. Treatment failure requiring surgery occurs in 0-4.1% of the patients having EMMA as the primary and only treatment. Treatment failure requiring surgery goes up slightly to 6.8% if post-surgical patients are included. When EMMA is used as postsurgical adjunctive the risk of recurrence is 1.4-8.9% compared to 10-20% in surgical series. EMMA has minimal morbidity and it is feasible under local anaesthesia or slight sedation in the majority of cases.

Conclusion: There is cumulative low-quality evidence in the literature that EMMA may be able to modify the natural course of the disease. It appears effective in controlling progression of CSDHs in patients having it as a primary standing alone treatment and it reduces the risk of recurrence and the need for surgical intervention in refractory postsurgical cases or as a postsurgical adjunctive treatment with minimal morbidity (recommendation: C).

Keywords: Chronic subdural haematoma; Embolization; Middle meningeal artery; Therapeutic.

© 2023 The Authors.

Figures

figs1
figs1

References

    1. Ban S.P., Hwang G., Byoun H.S., Kim T., Lee S.U., Bang J.S., Han J.H., Kim C.Y., Kwon O.K., Oh C.W. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286(3):992–999.
    1. Bender M.B., Christoff N. Nonsurgical treatment of subdural hematomas. Arch. Neurol. 1974;31(2):73–79.
    1. Brennan P.M., Kolias A.G., Joannides A.J., Shapey J., Marcus H.J., Gregson B.A., Grover P.J., Hutchinson P.J., Coulter I.C., Collaborative B.N.T.R. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J. Neurosurg. 2017:1–8.
    1. Catapano J.S., Koester S.W., Hanalioglu S., Farhadi D.S., Naik A., Hartke J.N., Tunc O., Winkler E.A., Chang S.W., Lawton M.T., Jadhav A.P., Ducruet A.F., Albuquerque F.C. Middle meningeal artery embolization associated with reduced chronic subdural hematoma volume and midline shift in the acute postoperative period. J. Neurointerventional Surg. 2023
    1. Catapano J.S., Koester S.W., Srinivasan V.M., Rumalla K., Baranoski J.F., Rutledge C., Cole T.S., Winkler E.A., Lawton M.T., Jadhav A.P., Ducruet A.F., Albuquerque F.C. Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. J. Neurointerventional Surg. 2022;14(8):804–806.
    1. Dian J., Linton J., Shankar J.J. Risk of recurrence of subdural hematoma after EMMA vs surgical drainage - systematic review and meta-analysis. Intervent Neuroradiol. 2021;27(4):577–583.
    1. Dicpinigaitis A.J., Al-Mufti F., Cooper J.B., Faraz Kazim S., Couldwell W.T., Schmidt M.H., Gandhi C.D., Cole C.D., Bowers C.A. Nationwide trends in middle meningeal artery embolization for treatment of chronic subdural hematoma: a population-based analysis of utilization and short-term outcomes. J. Clin. Neurosci. 2021;94:70–75.
    1. Fantoni M., Eliezer M., Serrano F., Civelli V., Labeyrie M.A., Saint-Maurice J.P., Houdart E. High frequency of ophthalmic origin of the middle meningeal artery in chronic subdural hematoma. Neuroradiology. 2020;62(5):639–644.
    1. Foreman P., Goren O., Griessenauer C.J., Dalal S.S., Weiner G., Schirmer C.M. Middle meningeal artery embolization for chronic subdural hematomas: cautious optimism for a challenging pathology. World Neurosurg. 2019;126:528–529.
    1. Gilligan J., Gologorsky Y. Middle meningeal artery embolization for chronic subdural hematoma: current state and future directions. World Neurosurg. 2020;139:622–623.
    1. Haldrup M., Munyemana P., Ma'aya A., Jensen T.S.R., Fugleholm K. Surgical occlusion of middle meningeal artery in treatment of chronic subdural haematoma: anatomical and technical considerations. Acta Neurochir. 2021;163(4):1075–1081.
    1. Holl D.C., Volovici V., Dirven C.M.F., Peul W.C., van Kooten F., Jellema K., van der Gaag N.A., Miah I.P., Kho K.H., den Hertog H.M., Lingsma H.F., Dammers R., (DSHR), D. C. S. H. R. G. Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future. World Neurosurg. 2018;116:402–411.e2.
    1. Hutchinson P.J., Edlmann E., Bulters D., Zolnourian A., Holton P., Suttner N., Agyemang K., Thomson S., Anderson I.A., Al-Tamimi Y.Z., Henderson D., Whitfield P.C., Gherle M., Brennan P.M., Allison A., Thelin E.P., Tarantino S., Pantaleo B., Caldwell K., Davis-Wilkie C., Mee H., Warburton E.A., Barton G., Chari A., Marcus H.J., King A.T., Belli A., Myint P.K., Wilkinson I., Santarius T., Turner C., Bond S., Kolias A.G., Collaborative B.N.T.R., Collaborators D.-C.T. Trial of dexamethasone for chronic subdural hematoma. N. Engl. J. Med. 2020;383(27):2616–2627.
    1. Jiang R., Zhao S., Wang R., Feng H., Zhang J., Li X., Mao Y., Yuan X., Fei Z., Zhao Y., Yu X., Poon W.S., Zhu X., Liu N., Kang D., Sun T., Jiao B., Liu X., Yu R., Gao G., Hao J., Su N., Yin G., Lu Y., Wei J., Hu J., Hu R., Li J., Wang D., Wei H., Tian Y., Lei P., Dong J.F. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized ClinicalTrial. JAMA Neurol. 2018;75(11):1338–1346.
    1. Joyce E., Bounajem M.T., Scoville J., Thomas A.J., Ogilvy C.S., Riina H.A., Tanweer O., Levy E.I., Spiotta A.M., Gross B.A., Jankowitz B.T., Cawley C.M., Khalessi A.A., Pandey A.S., Ringer A.J., Hanel R., Ortiz R.A., Langer D., Levitt M.R., Binning M., Taussky P., Kan P., Grandhi R. Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases. Neurosurg. Focus. 2020;49(4):E5.
    1. Kan P., Maragkos G.A., Srivatsan A., Srinivasan V., Johnson J., Burkhardt J.K., Robinson T.M., Salem M.M., Chen S., Riina H.A., Tanweer O., Levy E.I., Spiotta A.M., Kasab S.A., Lena J., Gross B.A., Cherian J., Cawley C.M., Howard B.M., Khalessi A.A., Pandey A.S., Ringer A.J., Hanel R., Ortiz R.A., Langer D., Kelly C.M., Jankowitz B.T., Ogilvy C.S., Moore J.M., Levitt M.R., Binning M., Grandhi R., Siddiq F., Thomas A.J. Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery. 2021;88(2):268–277.
    1. Link T.W., Boddu S., Paine S.M., Kamel H., Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery. 2019;85(6):801–807.
    1. Liu Z., Wang Y., Tang T., Zhang Y., Sun Y., Kuang X., Wei T., Zhou L., Peng A., Cao D., Hongsheng W., Qi W., Chenyi W., Shan Q. Time and influencing factors to chronic subdural hematoma resolution following middle meningeal artery embolization. World Neurosurg. 2023
    1. Martinez-Perez R., Rayo N., Tsimpas A. Endovascular Embolisation of the Middle Meningeal Artery to Treat Chronic Subdural Haematomas: Effectiveness, Safety, and the Current Controversy. A Systematic Review. 2020. Neurologia (Engl Ed)
    1. Matsumoto H., Hanayama H., Okada T., Sakurai Y., Minami H., Masuda A., Tominaga S., Miyaji K., Yamaura I., Yoshida Y. Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. J. Clin. Neurosci. 2018;49:40–47.
    1. McCann C.P., Brandel M.G., Wali A.R., Steinberg J.A., Pannell J.S., Santiago-Dieppa D.R., Khalessi A.A. Safety of middle meningeal artery embolization for treatment of subdural hematoma: a nationwide propensity score matched analysis. J Cerebrovasc Endovasc Neurosurg. 2023
    1. Mehta V., Harward S.C., Sankey E.W., Nayar G., Codd P.J. Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature. J. Clin. Neurosci. 2018;50:7–15.
    1. Miah I.P., Holl D.C., Blaauw J., Lingsma H.F., den Hertog H.M., Jacobs B., Kruyt N.D., van der Naalt J., Polinder S., Groen R.J.M., Kho K.H., van Kooten F., Dirven C.M.F., Peul W.C., Jellema K., Dammers R., van der Gaag N.A., Collaborators D. Dexamethasone versus surgery for chronic subdural hematoma. N. Engl. J. Med. 2023;388(24):2230–2240.
    1. Mohamed S., Villabona A., Kennion O., Padmananbhan R., Siddiqui A., Khan S., Prasad M., Mukerji N. Middle meningeal artery embolisation for chronic subdural haematomas: the first prospective UK study. Br. J. Neurosurg. 2022:1–6.
    1. Mori K., Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol. Med.-Chir. 2001;41(8):371–381.
    1. Nia A.M., Srinivasan V.M., Lall R.R., Kan P. Middle meningeal artery embolization for chronic subdural hematoma: a national database study of 191 patients in the United States. World Neurosurg. 2021;153:e300–e307.
    1. Onyinzo C., Berlis A., Abel M., Kudernatsch M., Maurer C.J. Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone. J. Neurointerventional Surg. 2022;14(3):297–300.
    1. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., Chou R., Glanville J., Grimshaw J.M., Hróbjartsson A., Lalu M.M., Li T., Loder E.W., Mayo-Wilson E., McDonald S., McGuinness L.A., Stewart L.A., Thomas J., Tricco A.C., Welch V.A., Whiting P., Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
    1. Phillips B., Ball C., Sackett D., Badenoch D., Straus S., Haynes B., Dawes M., Howick J. 2009. Oxford Centre for Evidence-Based Medicine-Levels of Evidence. March 2009)
    1. Pichert G., Henn V. [Conservative therapy of chronic subdural hematomas] Schweiz. Med. Wochenschr. 1987;117(47):1856–1862.
    1. Piergallini L., Dargazanli C., Derraz I., Costalat V. Immediate development of dural arteriovenous fistula after middle meningeal artery embolization: first angiographic demonstration. World Neurosurg. 2019;128:606–610.e1.
    1. Raviskanthan S., Mortensen P.W., Zhang Y.J., Lee A.G. Bilateral abducens nerve palsies after middle meningeal artery embolization for chronic subdural hematoma. J. Neuro Ophthalmol. 2021;42(2):e505–e507.
    1. Salem M.M., Kuybu O., Nguyen Hoang A., Baig A.A., Khorasanizadeh M., Baker C., Hunsaker J.C., Mendez A.A., Cortez G., Davies J.M., Narayanan S., Cawley C.M., Riina H.A., Moore J.M., Spiotta A.M., Khalessi A.A., Howard B.M., Hanel R., Tanweer O., Levy E.I., Grandhi R., Lang M.J., Siddiqui A.H., Kan P., Ogilvy C.S., Gross B.A., Thomas A.J., Jankowitz B.T., Burkhardt J.K. Middle meningeal artery embolization for chronic subdural hematoma: predictors of clinical and radiographic failure from 636 embolizations. Radiology. 2023;307(4)
    1. Schucht P., Fischer U., Fung C., Bernasconi C., Fichtner J., Vulcu S., Schöni D., Nowacki A., Wanderer S., Eisenring C., Krähenbühl A.K., Mattle H.P., Arnold M., Söll N., Tochtermann L., Z'Graggen W., Jünger S.T., Gralla J., Mordasini P., Dahlweid F.M., Raabe A., Beck J. Follow-up computed tomography after evacuation of chronic subdural hematoma. N. Engl. J. Med. 2019;380(12):1186–1187.
    1. Shotar E., Premat K., Barberis E., Talbi A., Lenck S., Cohen C., Degos V., Sourour N.A., Mathon B., Clarençon F. Dural arteriovenous fistula formation following bilateral middle meningeal artery embolization for the treatment of a chronic subdural hematoma: a case report. Acta Neurochir. 2021;163(4):1069–1073.
    1. Shotar E., Premat K., Lenck S., Degos V., Marijon P., Pouvelle A., Pouliquen G., Mouyal S., Abi Jaoude S., Sourour N.A., Mathon B., Clarençon F. Angiographic Anatomy of the Middle Meningeal Artery in Relation to Chronic Subdural Hematoma Embolization. Clin. Neuroradiol. 2021;32(1):57–67.
    1. Sioutas G.S., Mouchtouris N., Saiegh F.A., Naamani K.E., Amllay A., Becerril-Gaitan A., Velagapudi L., Gooch M.R., Herial N.A., Jabbour P., Rosenwasser R.H., Tjoumakaris S.I. Middle meningeal artery embolization for subdural hematoma: an institutional cohort and propensity score-matched comparison with conventional management. Clin. Neurol. Neurosurg. 2023;233
    1. Srivatsan A., Mohanty A., Nascimento F.A., Hafeez M.U., Srinivasan V.M., Thomas A., Chen S.R., Johnson J.N., Kan P. Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg. 2019;122:613–619.
    1. Starnoni D., Giammattei L., Messerer M., Daniel R.T. Letter to the editor regarding: "middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg. 2019;124:480–481.
    1. Tempaku A., Yamauchi S., Ikeda H., Tsubota N., Furukawa H., Maeda D., Kondo K., Nishio A. Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: five cases and a review of the literature. Intervent Neuroradiol. 2015;21(3):366–371.
    1. Yang W., Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg. Clin. 2017;28(2):205–210.
    1. Yu J., Guo Y., Xu B., Xu K. Clinical importance of the middle meningeal artery: a review of the literature. Int. J. Med. Sci. 2016;13(10):790–799.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever